Cellebrite DI (NASDAQ:CLBT) Shares Gap Up Following Analyst Upgrade

Cellebrite DI Ltd. (NASDAQ:CLBT) gapped up before the market opened on Thursday after Needham & Company LLC raised their price target on the stock from $22.00 to $24.00. The stock had previously closed at $15.97, but opened at $18.80. Needham & Company LLC currently has a buy rating on the stock. Cellebrite DI shares last traded at $19.91, with a volume of 913,167 shares traded.

A number of other analysts have also recently issued reports on the company. Weiss Ratings raised Cellebrite DI from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday, November 7th. Wall Street Zen lowered shares of Cellebrite DI from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Lake Street Capital cut their price target on Cellebrite DI from $24.00 to $22.00 and set a “buy” rating on the stock in a report on Friday, August 15th. Finally, JPMorgan Chase & Co. raised their price target on shares of Cellebrite DI from $20.00 to $23.00 and gave the company an “overweight” rating in a research report on Wednesday, September 24th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $23.00.

Hedge Funds Weigh In On Cellebrite DI

Hedge funds and other institutional investors have recently modified their holdings of the company. Y Intercept Hong Kong Ltd purchased a new position in Cellebrite DI during the 2nd quarter valued at approximately $657,000. Harbor Capital Advisors Inc. grew its stake in Cellebrite DI by 19.4% in the second quarter. Harbor Capital Advisors Inc. now owns 145,692 shares of the company’s stock worth $2,331,000 after purchasing an additional 23,638 shares in the last quarter. Venturi Wealth Management LLC purchased a new stake in Cellebrite DI in the second quarter worth about $224,000. MQS Management LLC bought a new position in Cellebrite DI in the second quarter worth approximately $256,000. Finally, Nordea Investment Management AB raised its holdings in Cellebrite DI by 2.1% in the second quarter. Nordea Investment Management AB now owns 174,734 shares of the company’s stock worth $2,766,000 after purchasing an additional 3,644 shares in the last quarter. 45.88% of the stock is owned by institutional investors.

Cellebrite DI Price Performance

The firm has a market capitalization of $4.77 billion, a PE ratio of -26.19, a price-to-earnings-growth ratio of 3.16 and a beta of 1.28. The company’s fifty day simple moving average is $17.72 and its 200-day simple moving average is $16.69.

Cellebrite DI (NASDAQ:CLBT) last released its quarterly earnings results on Wednesday, November 12th. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.13 by ($0.05). The company had revenue of $126.03 million for the quarter, compared to analyst estimates of $122.98 million. Cellebrite DI had a positive return on equity of 23.92% and a negative net margin of 34.56%.The firm’s revenue for the quarter was up 17.9% on a year-over-year basis. During the same quarter last year, the company earned $0.14 EPS. Cellebrite DI has set its FY 2025 guidance at EPS. Q4 2025 guidance at EPS. As a group, equities research analysts anticipate that Cellebrite DI Ltd. will post 0.3 earnings per share for the current fiscal year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.